Treatment of Fibromyalgia With the FibroNova Neuromodulation Device
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel Clauw, MD
University of Michigan
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
Ori Elkayam, MDNot, yet, recruiting
- Clinical Research Professionals
Chesterfield, Missouri, United States
Daniel Mattson, MDRecruiting - Clinvest Headlands Research
Springfield, Missouri, United States
David True, MDRecruiting - Gershon Pain Specialists
Virginia Beach, Virginia, United States
Steven Gershon, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 Mar 2024
- Primary completion
- 1 Mar 2025
- Completion
- 1 Jun 2025
- Last update posted
- 11 Apr 2024
- Registered enrollment
- 170
- Registry id
- NCT06271746
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.